Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-228-9 | CAS number: 2390-54-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
Test material
- Reference substance name:
- 2-[4-(dimethylamino)phenyl]-3,6-dimethylbenzothiazolium chloride
- EC Number:
- 219-228-9
- EC Name:
- 2-[4-(dimethylamino)phenyl]-3,6-dimethylbenzothiazolium chloride
- Cas Number:
- 2390-54-7
- Molecular formula:
- C17H19N2S.Cl
- IUPAC Name:
- 2-[4-(dimethylamino)phenyl]-3,6-dimethylbenzothiazolium chloride
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- The test item was administered at a single dose by gavage using a feeding tube.
In order to get the test item in a solution or suspension, which is applicable to the animals, aqua ad injectionem (AlleMan Pharma, lot no. 605070, expiry date: 30/04/2017) was evaluated as vehicle and was considered to be adequate. This vehicle was chosen due to its non-toxic characteristics.
For all animals of the first step, 0,3 g of the test item was dissolved in the vehicle to gain a final volume of 10 mL and to achieve a dose of 300 mg/kg body weight at a dose volume of 10 mL/kg body weight.
For all animals of the second and third step, 0, 05 g of the test item was dissolved in the vehicle to gain a final volume of 10 mL and to achieve a dose of 50 mg/kg body weight at a dose volume of 10 mL/kg body weight. - Doses:
- Animals were treated with test item at a dose of 50 mg/kg bw and at a dose of 300 mg/kg bw.
- No. of animals per sex per dose:
- 3 Female Rats/ 300 mg/kg body weigh
6 Female Rats/ 50 mg/kg body weight - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: once daily until the end of the observation period.
- Frequency of weighing: on day 1 (prior to the administration) and on days 8 and 15.
- Necropsy performed: yes
- Other examinations performed: clinical signs, body weight, morbidity and mortality.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50 cut-off
- Effect level:
- 200 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All animals that were treated with test item at a dose of 50 mg/kg bw (step 2 and 3) survived until the end of the study showing signs of toxicity.
All animals treated with the test item at a dose of 300 mg/kg bw (step 1) died spontaneously within 60 minutes post dosing. - Clinical signs:
- other: The most relevant clinical findings in the animals treated with the test item at a dose of 300 mg/kg bw were reduced spontaneous activity, slow movements, piloerection, ataxia, half eyelid-closure, prone position, cyanosis and abnormal breathing. The most
- Gross pathology:
- Macroscopic findings of surviving animals: At necropsy, no macroscopic findings were observed in any animal of any step.
Macroscopic findings of animals not having survived until the end of the observation period: Necropsy revealed dark discoloured intestinal sections such as duodenum, jejunum, ileum and caecum.
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- Under the conditions of the present study, a single oral application of the test item Basic Yellow 1 to rats at a dose of 300 mg/kg body weight was associated with signs of toxicity and mortality.
Under the conditions of the present study, a single oral application of the test item Basic Yellow 1 to rats at a dose of 50 mg/kg body weight was associated with signs of toxicity but no mortality.
The median lethal dose of Basic Yellow 1 after a single oral administration to female rats, observed over a period of 14 days is:
LD50 cut-off (rat): 200 mg/ kg bw - Executive summary:
One group of three female WISTAR Crl: WI(Han) rats were treated with the test item by oral gavage administration at a dosage of 300 mg/kg body weight (step 1). The test item was suspended in aqua ad injectionem (sterile water) at a concentration of 30 mg/mL and administered at a dose volume of 10 mL/kg.
Two groups each of three female WISTAR Crl: WI(Han) rats were treated with the test item by oral gavage administration at a dosage of 50 mg/kg body weight (step 2 and 3). The test item was suspended in aqua ad injectionem (sterile water) at a concentration of 5 mg/mL and administered at a dose volume of 10 mL/kg.
All animals used in the study after their entrance at BSL were allowed to acclimatise to the laboratory conditions for at least 5 days. The animals were observed on delivery, on inclusion in the study and before administration for mortality/morbidity and other clinical signs. All animals were examined for clinical signs several times on the day of dosing and once daily until the end of the observation period. Their body weights were recorded on day 1 (prior to the administration) and on days 8 and 15. All animals were necropsied and examined macroscopically.
ll animals treated with the test item at a dose of 300 mg/kg bw (step 1) died spontaneously within 60 minutes post dosing.
The most relevant clinical findings in the animals treated with the test item at a dose of 300 mg/kg bw were reduced spontaneous activity, slow movements, piloerection, ataxia, half eyelid-closure, prone position, cyanosis and abnormal breathing.
All animals that were treated with test item at a dose of 50 mg/kg bw (step 2 and 3) survived until the end of the study showing signs of toxicity.
The most relevant clinical findings in the animals treated with the test item at a dose of 50 mg/kg bw were reduced spontaneous activity, hunched posture, piloerection, prone position, half eyelid-closure, ataxia, slow movements and sunken flanks. All animals recovered within up to 3 days post-dose.
Throughout the 14-day observation period, the weight gain of the surviving animals was within the normal range of variation for this strain.
Macroscopic findings of surviving animals:
At necropsy, no macroscopic findings were observed in any animal of any step.
Macroscopic findings of animals not having survived until the end of the observation period:
Necropsy revealed dark discoloured intestinal sections such as duodenum, jejunum, ileum and caecum.
Conclusion
Under the conditions of the present study, a single oral application of the test item Basic Yellow 1 to rats at a dose of 300 mg/kg body weight was associated with signs of toxicity and mortality.
Under the conditions of the present study, a single oral application of the test item Basic Yellow 1 to rats at a dose of 50 mg/kg body weight was associated with signs of toxicity but no mortality.
The median lethal dose of Basic Yellow 1 after a single oral administration to female rats, observed over a period of 14 days is:
LD50 cut-off (rat): 200 mg/ kg bw
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.